2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$17.56-$0.01 (-0.06%)
Price as of Oct 02, 2026 5:59 PM EDT- $1.9BMarket Cap
- -21.39%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$17.56-$0.01 (-0.06%)
SRPT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.57 | ||
Change | -$0.65 (-3.57%) | ||
Open | $18.14 | ||
High | $18.25 | ||
Low | $17.52 | ||
Previous Close | $18.22 | ||
Volume | 2,885,278 | ||
30-Day Average Volume | 2,941,072 | ||
1-Week Change | -4.46% | ||
1-Month Change | -17.63% | ||
1-Year Change | -21.39% | ||
3-Year Change | -85.51% | ||
5-Year Change | -81.71% | ||
Fundamentals | |||
Shares Outstanding | 105.6M | ||
Total Assets | $3.2B | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $401.3M | ||
Net Income | -$4.9M | ||
Free Cash Flow | $196.5M | ||
EBIT | $19.8M | ||
EBITDA | $30.2M | ||
Net Working Capital | $1.7B | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 71 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 1 | ||
P/E | -351 | ||
PEG | 3 | ||
Price/Free Cash Flow | 9 | ||
Price/Operating Cash Flow | 9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue